OTC Medicines

Browse OTC Medicines Content

(WASHINGTON, D.C.) – Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released the below statement following President Trump imposing a 25% tariff on imports from Mexico and Canada, which were originally set to take effect Tuesday, Feb. 4 at 12:01 a.m. EST. As of this morning, the Trump Administration has agreed to pause sweeping tariffs on Mexico for one month while the two sides work on an agreement.

Feb 3, 2025

The Consumer Healthcare Products Association (CHPA) today announced the recent hiring of Dr. Fred Meadows as its new Senior Director of Quality, Technical, and Regulatory Affairs and Dr. Caitlin Ondracek as its new Senior Director of Medical Science and Regulatory Affairs. Meadows will report to Dr. Marcia Howard, Vice President of Regulatory and Scientific Affairs, and Ondracek will report to Dr. Jay Sirois, Vice President of Regulatory and Scientific Affairs.

Jan 31, 2025

PCPC and CHPA recommend the removal of over-the-counter drug products such as sunscreens and medicated topical creams and lotions as defined by the U.S. Food and Drug Administration (FDA) from the scope of this proposed regulation.

Jan 16, 2025

We applaud the intentions of the proposed rule to expand access to needed products for contraception. We note, however, that the proposed rule raises significant challenges that would need to be addressed.

Dec 26, 2024

The Consumer Healthcare Products Association (CHPA) released a statement following the U.S. Food and Drug Administration (FDA) issuing a final rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use (ACNU).

Dec 23, 2024

CHPA members have been working diligently on assessing potential for nitrosamine formation from APIs used in OTC medicines.

Dec 20, 2024

The annual Monitoring the Future survey (MTF), conducted by researchers at the University of Michigan and funded by the National Institute on Drug Abuse (NIDA), shows that overall substance use self-reported by teens in 2024 remains low and below pre-pandemic levels, and, specifically, intentional misuse/abuse (“nonmedical use”) of over-the-counter (OTC) cough/cold medication has also remained low.

Dec 18, 2024

CHPA joined the Congressional Trademark Caucus, the International Trademark Association (INTA), and the U.S. Chamber of Commerce's Global Innovation Policy Center (GIPC) on Capitol Hill Wednesday for a discussion and programming on anti-counterfeiting initiatives. The program included remarks from U.S. Senators Chuck Grassley (R-IA) and Chris Coons (D-DE), a panel discussion with U.S. government officials, a fireside chat with brand owners, and interactive booths to inform congressional staff about how to spot counterfeit goods and how to educate consumers about how to protect themselves, ways to report criminal activity, and other important information.

Dec 13, 2024

(WASHINGTON, D.C.) — Today, the Consumer Healthcare Products Association (CHPA), the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) consumer healthcare products, announced the addition of 14 new members, four manufacturers and 10 associate members since July.

Dec 12, 2024

Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville released the below statement today following Rep. Brett Guthrie (KY-02) being selected to serve as Chairman of the House Energy and Commerce Committee in the 119th Congress:

Dec 9, 2024

Filter Results